Euihan Jung1, Sookjin Byun2, Hojin Lee1, Sang Yi Moon1, Hyuck Lee3. 1. Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea. 2. Infection Control Office, Dong-A University Hospital, Busan, Korea. 3. Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea. Electronic address: hleeid@dau.ac.kr.
Abstract
BACKGROUND: The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. METHODS: We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. RESULTS: During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). CONCLUSION: Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
BACKGROUND: The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. METHODS: We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. RESULTS: During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). CONCLUSION: Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
Authors: M Papadimitriou-Olivgeris; I Spiliopoulou; M Christofidou; D Logothetis; P Manolopoulou; V Dodou; F Fligou; M Marangos; E D Anastassiou Journal: Eur J Clin Microbiol Infect Dis Date: 2015-07-15 Impact factor: 3.267
Authors: Daniel E Freedberg; Margaret J Zhou; Margot E Cohen; Medini K Annavajhala; Sabrina Khan; Dagmara I Moscoso; Christian Brooks; Susan Whittier; David H Chong; Anne-Catrin Uhlemann; Julian A Abrams Journal: Intensive Care Med Date: 2018-06-23 Impact factor: 17.440
Authors: Srinivasa Nithin Gopalsamy; Michael H Woodworth; Tiffany Wang; Cynthia T Carpentieri; Nirja Mehta; Rachel J Friedman-Moraco; Aneesh K Mehta; Christian P Larsen; Colleen S Kraft Journal: Am J Med Sci Date: 2018-08-29 Impact factor: 2.378
Authors: Erik R Dubberke; Kathleen M Mullane; Dale N Gerding; Christine H Lee; Thomas J Louie; Harriet Guthertz; Courtney Jones Journal: Open Forum Infect Dis Date: 2016-06-20 Impact factor: 3.835
Authors: Kelly L Wyres; Jane Hawkey; Mirianne Mirčeta; Louise M Judd; Ryan R Wick; Claire L Gorrie; Nigel F Pratt; Jill S Garlick; Kerrie M Watson; David V Pilcher; Steve A McGloughlin; Iain J Abbott; Nenad Macesic; Denis W Spelman; Adam W J Jenney; Kathryn E Holt Journal: BMC Infect Dis Date: 2021-07-14 Impact factor: 3.090
Authors: Fernanda S Soares; Flávia C Amaral; Natália L C Silva; Matheus R Valente; Lorena K R Santos; Lívia H Yamashiro; Mara C Scheffer; Fernanda V E S Castanheira; Raphael G Ferreira; Laura Gehrke; José C Alves-Filho; Luciano P Silva; André Báfica; Fernando Spiller Journal: Front Immunol Date: 2017-12-22 Impact factor: 7.561
Authors: Sabine Engler-Hüsch; Thomas Heister; Nico T Mutters; Jan Wolff; Klaus Kaier Journal: BMC Health Serv Res Date: 2018-09-26 Impact factor: 2.655